Literature DB >> 8849266

Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.

L Wondrack1, M Massa, B V Yang, J Sutcliffe.   

Abstract

Searching through a collection of 124 Staphylococcus aureus clinical strains, we found one isolate, strain 01A1032, that inactivates 14- and 16-membered macrolides. The products of inactivation were purified from supernatant fluids of cultures exposed to erythromycin for 3 h and were found to be identical to products of inactivation from Escherichia coli strains that encode either an EreA or EreB esterase. Further, strain 01A1032 was shown to be resistant to azithromycin, a 15-membered macrolide, by an alternate mechanism, efflux. Thus, strain 01A1032 harbors determinants encoding an esterase activity that hydrolyzes 14- and 16-membered macrolides and a macrolide efflux system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849266      PMCID: PMC163245     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

Review 1.  Quantitative or semi-quantitative PCR: reality versus myth.

Authors:  F Ferre
Journal:  PCR Methods Appl       Date:  1992-08

2.  Plasmid-mediated pristinamycin resistance. PAC IIA: a new enzyme which modifies pristinamycin IIA.

Authors:  F L Goffic; M L Capmau; D Bonnet; C Cerceau; C Soussy; A Dublanchet; J Duval
Journal:  J Antibiot (Tokyo)       Date:  1977-08       Impact factor: 2.649

3.  Acid degradation of erythromycin A and erythromycin B.

Authors:  P Kurath; P H Jones; R S Egan; T J Perun
Journal:  Experientia       Date:  1971-04-15

Review 4.  Erythromycin resistance by ribosome modification.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

Review 5.  Insights into erythromycin action from studies of its activity as inducer of resistance.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

6.  Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2'-phosphotransferase I in Escherichia coli.

Authors:  N Noguchi; A Emura; H Matsuyama; K O'Hara; M Sasatsu; M Kono
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

7.  Substrate- and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol. lincomycin and erythromycin sites.

Authors:  R Fernandez-Munoz; R E Monro; R Torres-Pinedo; D Vazquez
Journal:  Eur J Biochem       Date:  1971-11-11

8.  Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus.

Authors:  C J Lai; B Weisblum
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary.

Authors:  M Matsuoka; K Endou; S Saitoh; M Katoh; Y Nakajima
Journal:  Biol Pharm Bull       Date:  1995-11       Impact factor: 2.233

10.  Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact.

Authors:  J I Ross; E A Eady; J H Cove; S Baumberg
Journal:  Gene       Date:  1995-02-03       Impact factor: 3.688

View more
  38 in total

Review 1.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  New erm Gene in Staphylococcus aureus clinical isolates.

Authors:  Mayumi Matsuoka; Matsuhisa Inoue; Yoshinori Nakajima; Yoshihiro Endo
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 3.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci.

Authors:  G Lina; A Quaglia; M E Reverdy; R Leclercq; F Vandenesch; J Etienne
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

5.  Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides.

Authors:  Anne-Laure Prunier; Brigitte Malbruny; Didier Tandé; Bertrand Picard; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

6.  Antibiotic resistance in Staphylococcus isolates obtained from fecal samples of healthy children.

Authors:  Elena Domínguez; Myriam Zarazaga; Carmen Torres
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

7.  Nasal carriage of Staphylococcus aureus in healthy humans with different levels of contact with animals in Tunisia: genetic lineages, methicillin resistance, and virulence factors.

Authors:  K Ben Slama; H Gharsa; N Klibi; A Jouini; C Lozano; E Gómez-Sanz; M Zarazaga; A Boudabous; C Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-11       Impact factor: 3.267

8.  Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.

Authors:  S Pereyre; P Gonzalez; B De Barbeyrac; A Darnige; H Renaudin; A Charron; S Raherison; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

9.  High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.

Authors:  Linda M Weigel; Rodney M Donlan; Dong Hyeon Shin; Bette Jensen; Nancye C Clark; Linda K McDougal; Wenming Zhu; Kimberlee A Musser; Jill Thompson; Donna Kohlerschmidt; Nellie Dumas; Ronald J Limberger; Jean B Patel
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

Review 10.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.